New

Chrome Plugin Live! Redefine the way you read FinTwit 🚀 Install Now

You have successfully sign out
Loading...
Shape
Agilent Technologies, Inc.
A
Shape
US Flag

NYSE

38B

Medical - Diagnostics & Research

Next Earning date - 25 Nov 2024

38B

Medical - Diagnostics & Research

Next Earning date - 25 Nov 2024

131.54USD
Shape1.35 ( 1.04%)
favorite-chart

Relative Strenght

72
favorite-chart

Volume Buzz

-10%
favorite-chart

Earning Acce

No
favorite-chart

Dist 52w H.

15%

Quote Panel

Shape
Updated October 29, 2024
1W -1.12 % 1M -11.27 % 3M -5.55 % 1Y 30.90 %

Key Metrics

Shape
  • Market Cap

    37.80B


  • Shares Outstanding

    287.33M


  • Share in Float

    286.18M


  • Dividende

    0.94


  • Earning Date

    25 Nov 2024


  • Price Target

    131.54


  • Average Volume

    1.48M


  • Beta

    1.055


  • Range

    96.8-155.35


  • Industry

    Medical - Diagnostics & Research


  • Website

    https://www.agilent.com


  • Sector

    Healthcare


Fundamentals

Shape

25.25x

P/E Ratio

5.82x

P/S Ratio

6.46x

P/B Ratio

0.5

Debt/Equity

21.7%

Net Margin

$4.8

EPS

How A compares to sector?

P/E Ratio

Relative Strength

Shape

A

Sector

loading...

Top 5 RS in Group

Symbol

Company

RS

5-Day Perf.

Forecast

Shape

$7B

Shape333%

2025-Revenue

$4.90

Shape405%

2025-EPS

$2B

Shape340%

2025-EBITDA

Analyst rating

No Data Available

Last analyst upgrade/downgrade

Wells Fargo

initialise

Previous: Equal-Weight

2024-08-27

Now: Overweight

Citigroup

upgrade

Previous: Neutral

2024-07-10

Now: Buy

Wolfe Research

downgrade

Previous: Not converted

2024-06-27

Now: Peer Perform

Jefferies

downgrade

Previous: Buy

2024-06-03

Now: Hold

Earnings GrowthShape

status-upYoY

Current

Estimates

Q4.22

arrow
arrow

+26%

1.53
vs 1.21

Q1.23

arrow
arrow

+13%

1.37
vs 1.21

Q2.23

arrow
arrow

+12%

1.27
vs 1.13

Q3.23

arrow
arrow

+7%

1.43
vs 1.34

Q4.23

arrow
arrow

-10%

1.38
vs 1.53

Q1.24

arrow
arrow

-6%

1.29
vs 1.37

Q2.24

arrow
arrow

-4%

1.22
vs 1.27

Q3.24

arrow
arrow

-8%

1.32
vs 1.43

Q4.24

arrow
arrow

+2%

1.41
vs 1.38

Q1.25

arrow
arrow

+6%

1.37
vs 1.29

Sales GrowthShape

status-upYoY

Current

Estimates

Q4.22

arrow
arrow

+11%

1.8B  vs 1.7B

Q1.23

arrow
arrow

+5%

1.8B  vs 1.7B

Q2.23

arrow
arrow

+7%

1.7B  vs 1.6B

Q3.23

arrow
arrow

-3%

1.7B  vs 1.7B

Q4.23

arrow
arrow

-9%

1.7B  vs 1.8B

Q1.24

arrow
arrow

-6%

1.7B  vs 1.8B

Q2.24

arrow
arrow

-8%

1.6B  vs 1.7B

Q3.24

arrow
arrow

-6%

1.6B  vs 1.7B

Q4.24

arrow
arrow

-1%

1.7B  vs 1.7B

Q1.25

arrow
arrow

+3%

1.7B  vs 1.7B

Return on EquityShape

status-upQoQ

Q4.22

arrow
arrow

+7%

0.07
vs 0.06

Q1.23

arrow
arrow

+6%

0.06
vs 0.07

Q2.23

arrow
arrow

+5%

0.05
vs 0.06

Q3.23

arrow
arrow

+2%

0.02
vs 0.05

Q4.23

arrow
arrow

+8%

0.08
vs 0.02

Q1.24

arrow
arrow

+6%

0.06
vs 0.08

Q2.24

arrow
arrow

+5%

0.05
vs 0.06

Q3.24

arrow
arrow

+5%

0.05
vs 0.05

Institutionnal OwnershipShape

status-upQoQ

Q3.22

arrow
arrow

907

907
vs 891

2%

Q4.22

arrow
arrow

984

984
vs 907

8%

Q1.23

arrow
arrow

999

999
vs 984

2%

Q2.23

arrow
arrow

957

957
vs 999

-4%

Q3.23

arrow
arrow

942

942
vs 957

-2%

Q4.23

arrow
arrow

1021

1K
vs 942

8%

Q1.24

arrow
arrow

1031

1K
vs 1K

1%

Q2.24

arrow
arrow

1015

1K
vs 1K

-2%

Earnings Growth

Latest News